NO20004053L - Glukokortikoid-selektive antiinflammatoriske midler - Google Patents

Glukokortikoid-selektive antiinflammatoriske midler

Info

Publication number
NO20004053L
NO20004053L NO20004053A NO20004053A NO20004053L NO 20004053 L NO20004053 L NO 20004053L NO 20004053 A NO20004053 A NO 20004053A NO 20004053 A NO20004053 A NO 20004053A NO 20004053 L NO20004053 L NO 20004053L
Authority
NO
Norway
Prior art keywords
glucocorticoid
inflammatory agents
selective anti
mammal
compounds
Prior art date
Application number
NO20004053A
Other languages
English (en)
Other versions
NO20004053D0 (no
Inventor
Michael J Coughlan
Steven W Elmore
Michael E Kort
Philip R Kym
Jimmie L Moore
John K Pratt
Alan X Wang
James P Edwards
Todd Kevin Jones
Original Assignee
Abbott Lab
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab, Ligand Pharm Inc filed Critical Abbott Lab
Publication of NO20004053D0 publication Critical patent/NO20004053D0/no
Publication of NO20004053L publication Critical patent/NO20004053L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20004053A 1998-02-13 2000-08-11 Glukokortikoid-selektive antiinflammatoriske midler NO20004053L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2394798A 1998-02-13 1998-02-13
US24783199A 1999-02-10 1999-02-10
PCT/US1999/003127 WO1999041256A1 (en) 1998-02-13 1999-02-12 Glucocorticoid-selective anti-inflammatory agents

Publications (2)

Publication Number Publication Date
NO20004053D0 NO20004053D0 (no) 2000-08-11
NO20004053L true NO20004053L (no) 2000-09-11

Family

ID=26697833

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004053A NO20004053L (no) 1998-02-13 2000-08-11 Glukokortikoid-selektive antiinflammatoriske midler

Country Status (20)

Country Link
EP (1) EP1053239B1 (no)
JP (1) JP2002503665A (no)
KR (1) KR20010040935A (no)
CN (1) CN1119348C (no)
AT (1) ATE230749T1 (no)
AU (1) AU766441B2 (no)
BG (1) BG64317B1 (no)
BR (1) BR9907788A (no)
CA (1) CA2320943A1 (no)
DE (1) DE69904804T2 (no)
DK (1) DK1053239T3 (no)
ES (1) ES2192035T3 (no)
HU (1) HUP0100460A3 (no)
IL (1) IL137508A0 (no)
NO (1) NO20004053L (no)
NZ (1) NZ506013A (no)
PL (1) PL193323B1 (no)
SK (1) SK284689B6 (no)
TR (1) TR200003094T2 (no)
WO (1) WO1999041256A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506766B1 (en) 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
CO5180649A1 (es) * 1999-09-01 2002-07-30 Abbott Lab Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
US6593480B2 (en) 1999-09-01 2003-07-15 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6329534B1 (en) 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6436986B1 (en) 1999-09-01 2002-08-20 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
ES2246292T3 (es) 2000-10-30 2006-02-16 Pfizer Products Inc. Moduladores de receptor glucocorticoide.
WO2003002548A1 (en) * 2001-06-29 2003-01-09 Abbott Laboratories A process for the preparation of chiral glucocorticoid receptor agents
US6608216B2 (en) 2001-06-29 2003-08-19 Abbott Laboratories Process for the preparation of chiral glucocorticoid receptor agents
US6518430B1 (en) * 2001-09-21 2003-02-11 Abbott Laboratories Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
AU2003202216A1 (en) 2002-01-14 2003-07-30 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
WO2003082787A1 (en) 2002-03-26 2003-10-09 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
CA2478156C (en) 2002-03-26 2011-02-15 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
EP1496892B1 (en) 2002-04-11 2011-01-26 Merck Sharp & Dohme Corp. 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP2006504678A (ja) 2002-08-21 2006-02-09 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
AU2003258050A1 (en) 2002-10-11 2004-05-04 Ligand Pharmaceuticals Incorporated 5-cycloalkenyl 5h-chromeno(3,4-f)quinoline derivatives as selective progesterone receptor modulator compounds
DE20301728U1 (de) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
CA2501833A1 (en) 2002-10-11 2004-04-22 Ligand Pharmaceuticals Incorporated 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5h-chromeno[3,4-f]quinolines as selective progesterone receptor modulator compounds
CA2512257A1 (en) 2003-01-03 2004-07-29 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20070088042A1 (en) 2004-09-09 2007-04-19 Meissner Robert S Fluorinated 4-azasteroid derivatives as androgen receptor modulators
US7235662B2 (en) 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7507843B2 (en) 2003-10-16 2009-03-24 Boehringer Ingelheim Pharmaceuticals, Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
CA2592514A1 (en) 2004-12-27 2006-07-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
PL1944290T3 (pl) * 2005-09-14 2014-07-31 Ayumi Pharmaceutical Corp Nowa pochodna 1-2-dihydrochinoliny mająca aktywność wiązania glukokortykoidowego receptora
CN102834406A (zh) 2009-06-16 2012-12-19 默沙东公司 作为糖皮质激素受体激动剂的新的[3.2-c]杂芳基甾体、其组合物和用途
US20120220590A1 (en) 2009-07-31 2012-08-30 Thombare Pravin S Novel compounds as modulators of glucocorticoid receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1043325B1 (en) * 1994-12-22 2004-06-16 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods

Also Published As

Publication number Publication date
DK1053239T3 (da) 2003-04-22
DE69904804D1 (de) 2003-02-13
HUP0100460A3 (en) 2003-03-28
HK1033308A1 (en) 2001-08-24
CN1296486A (zh) 2001-05-23
TR200003094T2 (tr) 2001-01-22
SK11972000A3 (sk) 2001-08-06
BR9907788A (pt) 2001-10-30
CA2320943A1 (en) 1999-09-19
IL137508A0 (en) 2001-07-24
PL193323B1 (pl) 2007-02-28
SK284689B6 (sk) 2005-09-08
HUP0100460A2 (hu) 2001-09-28
CN1119348C (zh) 2003-08-27
BG64317B1 (bg) 2004-09-30
AU2677399A (en) 1999-08-30
EP1053239B1 (en) 2003-01-08
DE69904804T2 (de) 2003-11-06
JP2002503665A (ja) 2002-02-05
NZ506013A (en) 2003-03-28
NO20004053D0 (no) 2000-08-11
EP1053239A1 (en) 2000-11-22
KR20010040935A (ko) 2001-05-15
ES2192035T3 (es) 2003-09-16
ATE230749T1 (de) 2003-01-15
WO1999041256A1 (en) 1999-08-19
BG104719A (en) 2001-05-31
AU766441B2 (en) 2003-10-16
PL343018A1 (en) 2001-07-30

Similar Documents

Publication Publication Date Title
DK1053239T3 (da) Gluccocorticoid-selektive, anti-inflammatoriske midler
DK1053240T3 (da) Glucocorticoid-selektiv antiinflammatoriske midler
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
EP1034164A4 (en) BETA-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
BR9910864A (pt) Compostos anti-inflamatórios para inibição de aderência celular
FI973087A7 (fi) Soluadheesion inhibiittoreita
BG105880A (en) Compounds useful as anti-inflammatory agents
BR9811099A (pt) Inibidores de urocinase
DE69925508D1 (de) Zelladhäsion- und entzündungshemmende immunosuppressive verbindungen
AU1617901A (en) Urea derivatives as anti-inflammatory agents
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
MY128261A (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
WO2000006137A3 (en) Glucocorticoid-selective anti-inflammatory agents
ZA979647B (en) Heterocyclic compounds, compositions and uses.
BG100248A (bg) Инхибитори на скваленсинтетаза
ZA979645B (en) Heterocyclic compounds, compositions and uses.
IT1274022B (it) Derivati della cumarina ad attivita' farmacologica, loro uso e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application